Taming the Flames: Assessment and Management of Atherosclerosis Risk
Video series with global experts discussing the assessment and management of atherosclerotic risk with a specific focus on the role of inflammation.
February 3, 2026
Session 1: What Has Research Taught Us? – With Peter Libby, MD, and Paul M. Ridker, MD, MPH
Session 2: How Can We Measure Inflammation in Clinical Practice? – With Alberto Lorenzatti, MD, and Viviane Z. Rocha, MD
Session 3: The Cardio-Renal-Metabolic Risk Constellation – With Viviane Z. Rocha, MD, and Alberto Lorenzatti, MD
Session 4: Treating Inflammation Is Becoming Clinically Actionable – The Current and Future Landscape of Anti-Inflammatory Therapies for ASCVD – With Paul M. Ridker, MD, MPH, and Peter Libby, MD
Session 5: Obesity and Diabetes Drive Inflammation – With Roopa Mehta, MD, PhD, and Nasreen Alsayed, MD
Session 6: Can Newer Diabetes Drugs Manage Obesity, Diabetes and Atherosclerotic Risk All at Once? – With Nasreen Alsayed, MD, and Roopa Mehta, MD, PhD
The series was independently supported by Novo Nordisk.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
